Total Payments
$4,291
2024 Payments
$437.32
Companies
46
Transactions
235
Medicare Patients
2,704
Medicare Billing
$432,161
Payment Breakdown by Category
Food & Beverage$3,912 (91.2%)
Education$379.52 (8.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,912 | 224 | 91.2% |
| Education | $379.52 | 11 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $461.16 | 31 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $433.87 | 23 | $0 (2024) |
| Genentech USA, Inc. | $417.01 | 30 | $0 (2019) |
| PFIZER INC. | $231.05 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $214.35 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $203.82 | 8 | $0 (2020) |
| Pharmacyclics LLC, an AbbVie Company | $203.81 | 9 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $202.39 | 13 | $0 (2020) |
| ABBVIE INC. | $164.37 | 3 | $0 (2024) |
| GE HealthCare | $135.14 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $437.32 | 9 | Pharmacosmos Therapeutics Inc. ($125.74) |
| 2023 | $26.63 | 1 | Daiichi Sankyo Inc. ($26.63) |
| 2022 | $211.38 | 5 | GE HealthCare ($135.14) |
| 2021 | $108.11 | 6 | Seagen Inc. ($36.87) |
| 2020 | $196.63 | 12 | Ipsen Biopharmaceuticals, Inc ($21.98) |
| 2019 | $1,051 | 60 | PFIZER INC. ($122.84) |
| 2018 | $947.40 | 62 | E.R. Squibb & Sons, L.L.C. ($188.63) |
| 2017 | $1,313 | 80 | Novartis Pharmaceuticals Corporation ($221.48) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: HEMATOLOGY | ||||||
| 11/19/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/05/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/30/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $107.75 | General |
| Category: HEMATOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Oncology | ||||||
| 05/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Oncology | ||||||
| 04/08/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $135.14 | General |
| 08/31/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2022 | E.R. Squibb & Sons, L.L.C. | — | Education | In-kind items and services | $24.09 | General |
| 03/15/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| 10/29/2021 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Oncology | ||||||
| 10/25/2021 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Oncology | ||||||
| 10/21/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 05/26/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: ONCOLOGY | ||||||
| 05/12/2021 | TerSera Therapeutics LLC | Quzyttir (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Acute Care | ||||||
| 08/03/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: ONCOLOGY | ||||||
| 07/13/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $18.07 | General |
| Category: Oncology | ||||||
| 05/03/2020 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Hematology | ||||||
| 03/11/2020 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 611 | 1,154 | $250,310 | $102,507 |
| 2022 | 7 | 589 | 1,020 | $222,950 | $97,389 |
| 2021 | 8 | 719 | 1,282 | $287,460 | $129,918 |
| 2020 | 9 | 785 | 1,344 | $269,135 | $102,347 |
Total Patients
2,704
Total Services
4,800
Medicare Billing
$432,161
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 339 | 837 | $177,525 | $73,715 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 78 | 106 | $30,125 | $13,169 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 133 | $19,860 | $7,951 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $9,480 | $3,247 | 34.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $6,130 | $2,249 | 36.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,290 | $1,227 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,900 | $948.31 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 299 | 672 | $137,760 | $60,800 | 44.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 87 | 133 | $36,575 | $17,360 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $17,640 | $6,781 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 84 | $11,760 | $5,338 | 45.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $7,155 | $2,775 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $7,380 | $2,457 | 33.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $4,680 | $1,878 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 374 | 822 | $168,510 | $77,603 | 46.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 105 | 196 | $53,900 | $27,042 | 50.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 78 | 78 | $24,570 | $9,900 | 40.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 41 | $15,990 | $6,378 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 96 | $13,440 | $5,142 | 38.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $4,770 | $1,734 | 36.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 15 | $3,000 | $1,142 | 38.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $3,280 | $976.91 | 29.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 317 | 785 | $160,925 | $62,594 | 38.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 248 | 317 | $44,380 | $14,668 | 33.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 48 | 65 | $17,875 | $7,401 | 41.4% |
About Dr. Sonyo Shin, MD
Dr. Sonyo Shin, MD is a Medical Oncology healthcare provider based in Bridgewater, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124217971.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonyo Shin, MD has received a total of $4,291 in payments from pharmaceutical and medical device companies, with $437.32 received in 2024. These payments were reported across 235 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($3,912).
As a Medicare-enrolled provider, Shin has provided services to 2,704 Medicare beneficiaries, totaling 4,800 services with total Medicare billing of $432,161. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Bridgewater, NJ
- Active Since 10/17/2007
- Last Updated 09/20/2024
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1124217971
Products in Payments
- OPDIVO (Biological) $325.45
- Imbruvica (Drug) $171.98
- KEYTRUDA (Biological) $166.20
- IMBRUVICA (Drug) $134.72
- AFINITOR (Drug) $133.18
- MONOFERRIC (Drug) $125.74
- TASIGNA (Drug) $125.60
- VENCLEXTA (Drug) $124.74
- JEVTANA (Drug) $91.64
- FOTIVDA (Drug) $89.99
- IBRANCE (Drug) $76.62
- Abraxane (Drug) $76.22
- Alecensa (Biological) $71.54
- Avastin (Biological) $68.11
- TAGRISSO (Drug) $67.55
- GAZYVA (Biological) $66.50
- DARZALEX (Biological) $66.04
- VENCLEXTA (Biological) $65.87
- ELIQUIS (Drug) $65.60
- Xtandi (Drug) $62.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.